Rigel Pharmaceuticals Inc
RIGL· Nasdaq
Released May 1, 2012, before the open
10-Q filed May 1, 2012, 31 days after period end · 0001104659-12-030962
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| EPS Diluted | -$0.32 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 1, 2012 · 31 d after period end
1.8% from the close of Apr 30, 2012 to the close of May 1, 2012, the first after the release.